1. Home
  2. DAC vs VERA Comparison

DAC vs VERA Comparison

Compare DAC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Danaos Corporation

DAC

Danaos Corporation

HOLD

Current Price

$161.74

Market Cap

2.6B

ML Signal

HOLD

Logo Vera Therapeutics Inc.

VERA

Vera Therapeutics Inc.

HOLD

Current Price

$33.66

Market Cap

3.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAC
VERA
Founded
1972
2016
Country
Greece
United States
Employees
N/A
N/A
Industry
Marine Transportation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
3.0B
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
DAC
VERA
Price
$161.74
$33.66
Analyst Decision
Buy
Strong Buy
Analyst Count
2
10
Target Price
$112.50
$81.30
AVG Volume (30 Days)
101.2K
2.3M
Earning Date
05-14-2026
05-06-2026
Dividend Yield
3.00%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$472.48
P/E Ratio
$4.01
N/A
Revenue Growth
N/A
N/A
52 Week Low
$83.56
$23.05
52 Week High
$163.64
$56.05

Technical Indicators

Market Signals
Indicator
DAC
VERA
Relative Strength Index (RSI) 71.30 48.37
Support Level $121.29 $33.43
Resistance Level N/A $36.89
Average True Range (ATR) 2.89 1.96
MACD 0.27 -0.10
Stochastic Oscillator 87.94 39.83

Price Performance

Historical Comparison
DAC
VERA

About DAC Danaos Corporation

Danaos Corp is an international owner of containerships. It provides international seaborne transportation services by operating vessels in the containership sector of the shipping industry. The company's customers include HMM, MSC, Yang Ming, Hapag Lloyd, ZIM, Maersk, COSCO, OOCL, ONE, PIL, Sealead, Niledutch, Samudera, OSC, and Arkas. Geographically, the company operates in Australia, Asia, Europe, and America, with maximum revenue from the Australia-Asia region. It has two reporting segments: Container vessels and Drybulk vessels segment. It generates the majority of its revenue from Container vessels.

About VERA Vera Therapeutics Inc.

Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.

Share on Social Networks: